“Fed Proof” Your Bank Account with THESE 4 Simple Steps

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

Richard B. Hancock net worth and biography

Richard Hancock Biography and Net Worth

Director of Avid Bioservices

Mr. Hancock was appointed to the Board of Directors in November 2017 and served as our interim President and Chief Executive Officer from May 2019 to July 2020. Mr. Hancock has worked in the biologic CDMO industry for over 30 years in various operational and executive roles, serving most recently as President and Chief Executive Officer of Althea Technologies, Inc., a large molecule CDMO producing a wide range of biologics, vaccines and parenteral products. In addition to Althea, Mr. Hancock has held senior management positions at The Immune Response Corporation, and Hybritech Inc. (now part of Eli Lilly & Company), and he is currently the Chairman of the Board and Executive Director of Argonaut Manufacturing Services, Inc., a privately-owned CDMO focused on the biotechnology and life sciences industries. He also serves on the Board of Directors of Tempo Therapeutics, a privately-held company, focused on cell therapy, vaccine technology, and complex wounds. Mr. Hancock received a B.A. in Microbiology from Miami University.

What is Richard B. Hancock's net worth?: The estimated net worth of Richard B. Hancock is at least $956,146.40 as of December 15th, 2023. Mr. Hancock owns 78,760 shares of Avid Bioservices stock worth more than $956,146 as of November 17th. This net worth approximation does not reflect any other assets that Mr. Hancock may own. Learn More about Richard B. Hancock's net worth.
How do I contact Richard B. Hancock?: The corporate mailing address for Mr. Hancock and other Avid Bioservices executives is 2642 Michelle Drive Suite 200, TUSTIN CA, 92780. Avid Bioservices can also be reached via phone at (714) 508-6100 and via email at [email protected]. Learn More on Richard B. Hancock's contact information.
Has Richard B. Hancock been buying or selling shares of Avid Bioservices?: Richard B. Hancock has not been actively trading shares of Avid Bioservices within the last three months. Most recently, on Friday, December 15th, Richard B. Hancock bought 23,000 shares of Avid Bioservices stock. The stock was acquired at an average cost of $5.86 per share, with a total value of $134,780.00. Following the completion of the transaction, the director now directly owns 78,760 shares of the company's stock, valued at $461,533.60. Learn More on Richard B. Hancock's trading history.
Who are Avid Bioservices' active insiders?: Avid Bioservices' insider roster includes Mark Bamforth (Director), Nicholas Green (CEO), Richard Hancock (Director), Daniel Hart (CFO), and Mark Ziebell (General Counsel). Learn More on Avid Bioservices' active insiders.
Are insiders buying or selling shares of Avid Bioservices?: In the last twelve months, Avid Bioservices insiders bought shares 1 times. They purchased a total of 23,000 shares worth more than $134,780.00. In the last twelve months, insiders at the biopharmaceutical company sold shares 15 times. They sold a total of 50,858 shares worth more than $423,264.89. The most recent insider tranaction occured on October, 14th when insider Matthew R Kwietniak sold 119 shares worth more than $1,207.85. Insiders at Avid Bioservices own 3.1% of the company. Learn More about insider trades at Avid Bioservices.
Information on this page was last updated on 10/14/2024.

Richard B. Hancock Insider Trading History at Avid Bioservices

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/15/2023	Buy	23,000	$5.86	$134,780.00	78,760
6/6/2023	Sell	5,000	$16.37	$81,850.00	39,134
5/1/2023	Sell	5,000	$17.92	$89,600.00	39,134
4/3/2023	Sell	5,000	$18.46	$92,300.00	39,134
3/1/2023	Sell	5,000	$16.59	$82,950.00	39,134
2/1/2023	Sell	5,000	$16.02	$80,100.00	39,134
1/12/2023	Sell	5,000	$16.00	$80,000.00	39,134
12/2/2022	Sell	10,000	$16.11	$161,100.00	36,881
10/3/2022	Sell	5,000	$18.43	$92,150.00	36,881
8/1/2022	Sell	5,000	$19.40	$97,000.00	37,215
7/5/2022	Sell	5,000	$16.03	$80,150.00	35,201
6/27/2022	Sell	7,537	$16.07	$121,119.59	35,201
6/24/2022	Sell	2,463	$16.02	$39,457.26	38,936
4/1/2022	Sell	5,000	$21.21	$106,050.00	35,200
3/1/2022	Sell	5,000	$19.86	$99,300.00
2/1/2022	Sell	5,000	$18.81	$94,050.00
1/3/2022	Sell	5,000	$27.53	$137,650.00
12/1/2021	Sell	5,000	$30.90	$154,500.00
11/15/2021	Sell	5,000	$32.47	$162,350.00
3/13/2020	Buy	12,500	$3.99	$49,875.00	22,500
9/10/2019	Buy	10,000	$5.09	$50,900.00

Richard B. Hancock Buying and Selling Activity at Avid Bioservices

Avid Bioservices Company Overview

Avid Bioservices, Inc. operates as a contract development and manufacturing organization for the biotechnology and biopharmaceutical industries in the United States. It provides process development and current good manufacturing practice clinical and commercial manufacturing services of biologics, including clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, regulatory submission and support, upstream and downstream development and optimization, analytical methods development, cell line development, testing, and characterization services. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is based in Tustin, California.

Today's Range

Now: $12.14

$12.02

$12.17

50 Day Range

MA: $10.85

$8.95

$12.45

2 Week Range

Now: $12.14

$4.07

$12.48

Volume

3,576,492 shs

Average Volume

3,428,059 shs

Market Capitalization

$774.41 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.4